pLenti_dCas9-2xAM Citations (2)

Originally described in: enChIP systems using different CRISPR orthologues and epitope tags.
Fujita T, Yuno M, Fujii H BMC Res Notes. 2018 Feb 27;11(1):154. doi: 10.1186/s13104-018-3262-4. PubMed Journal

---

Articles Citing pLenti_dCas9-2xAM

Articles
Guidelines for optimized gene knockout using CRISPR/Cas9. Campenhout CV, Cabochette P, Veillard AC, Laczik M, Zelisko-Schmidt A, Sabatel C, Dhainaut M, Vanhollebeke B, Gueydan C, Kruys V. Biotechniques. 2019 Jun;66(6):295-302. doi: 10.2144/btn-2018-0187. Epub 2019 May 1. PubMed
Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer. Akincilar SC, Chua JYH, Ng QF, Chan CHT, Eslami-S Z, Chen K, Low JL, Arumugam S, Aswad L, Chua C, Tan IB, DasGupta R, Fullwood MJ, Tergaonkar V. Nucleic Acids Res. 2022 Jun 14. pii: 6605892. doi: 10.1093/nar/gkac479. PubMed

If you have published an article using this material, please email us at to have your article added to this page.